H.C. Wainwright Downgrades Immune Design (IMDZ) to Neutral following acquisition
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis downgraded Immune Design (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
